Q1 2022 Blueprint Medicines Corp Earnings Call Transcript
Morning. My name is Juan, and I will be your conference operator today. At this time, I would like to welcome everyone to the Blueprint Medicines First Quarter 2022 Financial Results Conference Call. (Operator Instructions) Thank you.
I would now like to turn the call over to your host, Jenna Cohen from Blueprint Medicines. Jenna, you may begin your conference.
Thank you, Juan. Good morning, everyone, and welcome to Blueprint Medicine's First Quarter 2022 Financial and Operating Results Conference Call. This morning, we issued a press release, which outlines the topics we plan to discuss today. You can access the press release as well as the slides that we'll be reviewing today, by going to the Investor set of our website at www.blueprintmedicines.com.
Today on our call Kate Haviland, our Chief Executive Officer, will discuss Blueprint Medicine's pillars for growth through 2023. Christy
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |